stockrowGuardant Health, Inc. (GH) vs Illumina, Inc. (ILMN)
- Guardant Health, Inc. GH 145.25 −5.33%
- Illumina, Inc. ILMN 211.04 +1.46%
Guardant Health, Inc. and Illumina, Inc. are both Diagnostics & Research companies. Illumina, Inc. is the larger, with a market value of $31.5B against $20.6B — 1.5× the size. Guardant Health, Inc. has negative trailing earnings, so its P/E is not meaningful; Illumina, Inc. trades at 35.6×. Guardant Health, Inc. grew revenue faster over the last twelve months: 41.7% against 5.83%. Illumina, Inc. has the higher net margin (19.7% vs −37.9%) and the higher return on invested capital (16.7% vs −25.7%). Across the 18 metrics below, Illumina, Inc. leads on 12 and Guardant Health, Inc. on 6.
Valuation
Profitability
| Metric | GH | ILMN | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 65.19% | 67.87% | 48.32% |
| Operating margin | (39.41%) | 21.18% | (5.68%) |
| Net margin | (37.93%) | 19.72% | (4.10%) |
| Free cash flow margin | (18.15%) | 23.29% | 0.00% |
| Return on equity | 153.90% | 32.39% | 0.00% |
| Return on assets | (30.68%) | 13.78% | (6.05%) |
| Return on invested capital | (25.68%) | 16.70% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack